Northern Trust
IMMX icon

Northern Trust’s Immix Biopharma IMMX Stock Holding History

Northern Trust’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.26M Buy
138,232
+37,574
+37% +$276K ﹤0.01% 3219
2025
Q4 		$526K Buy
100,658
+11,357
+13% +$46.7K ﹤0.01% 3638
2025
Q3 		$187K Sell
89,301
-4,587
-5% -$11K ﹤0.01% 4003
2025
Q2 		$194K Sell
93,888
-1,374
-1% -$2.77K ﹤0.01% 3944
2025
Q1 		$160K Buy
95,262
+56,348
+145% +$106K ﹤0.01% 4001
2024
Q4 		$85.6K Hold
38,914
– – ﹤0.01% 4183
2024
Q3 		$58K Hold
38,914
– – ﹤0.01% 4174
2024
Q2 		$77K Hold
38,914
– – ﹤0.01% 4107
2024
Q1 		$119K Buy
38,914
+14,536
+60% +$56.3K ﹤0.01% 4029
2023
Q4 		$169K Buy
+24,378
New +$110K ﹤0.01% 3951
2023
Q1 		– Sell
-19,151
Closed -$43.9K – 4603
2022
Q4 		$43.9K Hold
19,151
– – ﹤0.01% 4308
2022
Q3 		$26K Buy
+19,151
New +$41.9K ﹤0.01% 4498

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Northern Trust's IMMX Position: Q1 2026 in Review

Northern Trust increased its Immix Biopharma (IMMX) stake by 37% in Q1 2026, buying an estimated $276K and bringing the position to 138,232 shares worth $1.26M. The position accounts for ﹤0.01% of the portfolio, ranked #3219.

Northern Trust first reported a position in IMMX in Q3 2022 and has held it in 12 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Northern Trust held 138,232 shares of Immix Biopharma worth $1.26M as of Q1 2026.
  • Northern Trust bought 37,574 Immix Biopharma shares in Q1 2026, an estimated $276K.
  • Immix Biopharma made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3219 holding.
  • Northern Trust first reported a position in Immix Biopharma in Q3 2022 and has held it in 12 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.